Corrigendum: Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager.

Xinghui XiaoYing ChengXiaodong ZhengYuhang FangYu ZhangRui SunZhigang TianHaoyu Sun

Published in: Frontiers in immunology (2024)

[This corrects the article DOI: 10.3389/fimmu.2023.1113303.].

Keyphrases